These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24267055)

  • 1. Decreased ipsilateral [¹²³I]iododexetimide binding to cortical muscarinic receptors in unilaterally 6-hydroxydopamine lesioned rats.
    Knol RJ; de Bruin K; Opmeer B; Voorn P; Jonker AJ; van Eck-Smit BL; Booij J
    Nucl Med Biol; 2014 Jan; 41(1):90-5. PubMed ID: 24267055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of acetylcholine on binding of 4-[125I]iododexetimide to muscarinic brain receptors.
    Weckesser M; Fixmann A; Holschbach M; Müller-Gärtner HW
    Nucl Med Biol; 1998 Nov; 25(8):777-80. PubMed ID: 9863566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo.
    Bakker G; Vingerhoets WA; van Wieringen JP; de Bruin K; Eersels J; de Jong J; Chahid Y; Rutten BP; DuBois S; Watson M; Mogg AJ; Xiao H; Crabtree M; Collier DA; Felder CC; Barth VN; Broad LM; Bloemen OJ; van Amelsvoort TA; Booij J
    J Nucl Med; 2015 Feb; 56(2):317-22. PubMed ID: 25593117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I-iododexetimide and single-photon emission computed tomography in epilepsy.
    Müller-Gärtner HW; Mayberg HS; Fisher RS; Lesser RP; Wilson AA; Ravert HT; Dannals RF; Wagner HN; Uematsu S; Frost JJ
    Ann Neurol; 1993 Aug; 34(2):235-8. PubMed ID: 8338348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo characterization of 4-[125I]iododexetimide binding to muscarinic cholinergic receptors in the rat heart.
    Matsumura K; Uno Y; Scheffel U; Wilson AA; Dannals RF; Wagner HN
    J Nucl Med; 1991 Jan; 32(1):76-80. PubMed ID: 1988640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.
    Claus JJ; Dubois EA; Booij J; Habraken J; de Munck JC; van Herk M; Verbeeten B; van Royen EA
    Eur J Nucl Med; 1997 Jun; 24(6):602-8. PubMed ID: 9169565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA
    Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-123 N-methyl-4-iododexetimide: a new radioligand for single-photon emission tomographic imaging of myocardial muscarinic receptors.
    Hicks RJ; Kassiou M; Eu P; Katsifis AG; Garra M; Power J; Najdovski L; Lambrecht RM
    Eur J Nucl Med; 1995 Apr; 22(4):339-45. PubMed ID: 7607265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging muscarinic cholinergic receptors in human brain in vivo with Spect, [123I]4-iododexetimide, and [123I]4-iodolevetimide.
    Müller-Gärtner HW; Wilson AA; Dannals RF; Wagner HN; Frost JJ
    J Cereb Blood Flow Metab; 1992 Jul; 12(4):562-70. PubMed ID: 1618935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.
    Boundy KL; Barnden LR; Rowe CC; Reid M; Kassiou M; Katsifis AG; Lambrecht RM
    J Nucl Med; 1995 Jul; 36(7):1332-8. PubMed ID: 7790964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of partial volume correction on muscarinic cholinergic receptor imaging with single-photon emission tomography in patients with temporal lobe epilepsy.
    Weckesser M; Hufnagel A; Ziemons K; Griessmeier M; Sonnenberg F; Hackländer T; Langen KJ; Holschbach M; Elger CE; Müller-Gärtner H
    Eur J Nucl Med; 1997 Sep; 24(9):1156-61. PubMed ID: 9283110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist.
    Wilson AA; Dannals RF; Ravert HT; Frost JJ; Wagner HN
    J Med Chem; 1989 May; 32(5):1057-62. PubMed ID: 2785211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain.
    Araki T; Tanji H; Kato H; Imai Y; Mizugaki M; Itoyama Y
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):365-75. PubMed ID: 10974608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging with [
    Tang J; Xu Y; Liu C; Fang Y; Cao S; Zhao C; Huang H; Zou M; Chen Z
    Nucl Med Biol; 2020; 90-91():1-9. PubMed ID: 32861175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.
    Colloby SJ; Pakrasi S; Firbank MJ; Perry EK; Piggott MA; Owens J; Wyper DJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Neuroimage; 2006 Nov; 33(2):423-9. PubMed ID: 16959499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory.
    Wang Q; Wei X; Gao H; Li J; Liao J; Liu X; Qin B; Yu Y; Deng C; Tang B; Huang XF
    Neuroscience; 2014 May; 267():57-66. PubMed ID: 24613723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.